Phase II Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas.

Trial Profile

Phase II Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jun 2013

At a glance

  • Drugs Cetuximab (Primary)
  • Indications Osteosarcoma; Soft tissue sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Jul 2012 Actual patient number changed from 36 to 38 as reported by ClinicalTrials.gov.
    • 31 Jul 2012 Actual initiation date changed from 1 Mar 2005 to 1 Jun 2005 as reported by ClinicalTrials.gov.
    • 09 Sep 2011 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top